Wordt geladen...
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm
Drugs introduced over the past 25 years have benefitted many patients with acute myeloid leukemia (AML) and provided cure for some. Still, AML remains difficult to treat, and most patients will eventually die from their disease. Therefore, novel drugs and drug combinations are under intense investig...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2953881/ https://ncbi.nlm.nih.gov/pubmed/20538802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-05-285387 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|